Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$29.21

0.03 (0.10%)

, TSRO

Tesaro

$112.99

-1.01 (-0.89%)

14:50
08/17/17
08/17
14:50
08/17/17
14:50

Lynparza labeling could be a clearing event for Tesaro and Clovis, says Leerink

Leerink said of AstraZeneca's (AZN) Lynparza expanded label may be a "clearing event" for both Tesaro (TSRO) and Clovis (CLVS). The firm's analyst expects a roughly even split between the three PARP inhibitors in the second-line or greater, 2L, ovarian cancer maintenance setting.

AZN

AstraZeneca

$29.21

0.03 (0.10%)

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

CLVS

Clovis

$71.77

-0.11 (-0.15%)

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

AZN AstraZeneca
$29.21

0.03 (0.10%)

08/01/17
PART
08/01/17
UPGRADE
PART
Hold
AstraZeneca upgraded to Hold from Sell at Pareto
08/08/17
MSCO
08/08/17
NO CHANGE
MSCO
Morgan Stanley buyers of Clovis and Tesaro into Lynparza label decision
Morgan Stanley analyst Andrew Berens would be a buyer of Clovis (CLVS) and Tesaro (TSRO) ahead of the broad label decision for AstraZeneca's (AZN) Lynparza in 2L maintenance setting expected in Q3. Berens sees minimal fundamental impact to both stocks, even if AstraZeneca receives a broad label. He thinks a broad label will be limited to BRCA patients, or the FDA will place caveats as having inferior data outside of BRCA, and both stocks will benefit as an overhang is lifted.
08/09/17
PIPR
08/09/17
NO CHANGE
PIPR
Overweight
AstraZeneca recent selloff a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Richard Purkiss believes the recent negative MYSTIC update from AstraZeneca has created a long-term buying opportunity. 2017 marks an earnings trough year for the company, and the shares now trade at discounted valuation, Purkiss tells investors in a research note. He reiterates an Overweight rating on the shares with a GBP 51 price target.
08/09/17
LEER
08/09/17
NO CHANGE
Target $143
LEER
Market Perform
Tesaro Zejula off to 'strong initial launch, says Leerink
Leerink analyst Seamus Fernandez notes that Tesaro (TSRO) reported Q2 earnings with $25.9M in Zejula sales during its first quarter on the market following approval for second-line or greater ovarian cancer maintenance, more than doubling consensus estimates. With more than 1,500 new patient starts in the quarter, Zejula is off to a "strong" initial launch, he adds. However, the analyst believes it will likely soon face competition from Clovis' (CLVS) Rubraca and AstraZeneca's (AZN) Lynparza following their likely approvals in this setting. Fernandez reiterates a Market Perform rating and $143 price target on Tesaro's shares.
TSRO Tesaro
$112.99

-1.01 (-0.89%)

08/01/17
JANY
08/01/17
NO CHANGE
JANY
Neutral
Robust launch for Idhifa already reflected in Agios shares, says Janney Capital
Janney Capital analyst Debjit Chattopadhyay said he anticipates rapid adoption of Idhifa and expects a robust commercial launch led by Agios' (AGIO) partner Celgene (CELG), but he also believes this is reflected in the stock. The wholesale acquisition cost of $24,872 is significantly higher than Tesaro's (TSRO) Zejula and Clovis' (CLVS) Rubraca, noted Chattopadhyay, who added that the higher WAC and potentially longer median duration of therapy represents upside to his current estimates. He keeps a Neutral rating on Agios, which will receive a low double digit to mid teens royalty for Idhifa.
08/16/17
EVER
08/16/17
INITIATION
Target $121
EVER
In Line
Tesaro initiated with an In Line at Evercore ISI
Evercore ISI analyst Josh Schimmer initiated Tesaro with an In Line and a $121 price target.
CLVS Clovis
$71.77

-0.11 (-0.15%)

08/16/17
EVER
08/16/17
INITIATION
Target $73
EVER
In Line
Clovis initiated with an In Line at Evercore ISI
Evercore ISI analyst Josh Schimmer initiated Clovis with an In Line and a $73 price target.

TODAY'S FREE FLY STORIES

BANF

BancFirst

$55.20

0.95 (1.75%)

16:22
01/18/18
01/18
16:22
01/18/18
16:22
Hot Stocks
BancFirst to raise company minimum wage »

Executive Chairman David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$23.82

-0.3 (-1.24%)

16:22
01/18/18
01/18
16:22
01/18/18
16:22
Hot Stocks
Meritor realigns segments and leadership positions »

Meritor is realigning its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 13

    Feb

  • 14

    Feb

BANF

BancFirst

$55.20

0.95 (1.75%)

16:21
01/18/18
01/18
16:21
01/18/18
16:21
Earnings
BancFirst reports Q4 EPS 59c, consensus 69c »

Due to the signing of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHN

athenahealth

$125.53

-0.65 (-0.52%)

16:20
01/18/18
01/18
16:20
01/18/18
16:20
Initiation
athenahealth initiated  »

athenahealth initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

VIX

Volatility Index S&P 500 Options

16:20
01/18/18
01/18
16:20
01/18/18
16:20
Options
Closing CBOE SPX and VIX Index summary for January 18th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$99.86

-0.9 (-0.89%)

16:19
01/18/18
01/18
16:19
01/18/18
16:19
Hot Stocks
Breaking Hot Stocks news story on American Express »

American Express down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

MRCY

Mercury Systems

$51.26

-0.45 (-0.87%)

16:19
01/18/18
01/18
16:19
01/18/18
16:19
Hot Stocks
Mercury Systems receives $12.5M electronic surveillance subsystem order »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

HCLP

Hi-Crush Partners

$12.00

-0.05 (-0.41%)

16:18
01/18/18
01/18
16:18
01/18/18
16:18
Hot Stocks
Hi-Crush Partners increases distribution to 20c per unit for Q4 »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFBC

First Financial Bancorp

$27.75

-0.4 (-1.42%)

16:17
01/18/18
01/18
16:17
01/18/18
16:17
Earnings
First Financial Bancorp reports Q4 adjusted EPS 45c, consensus 40c »

Claude Davis, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

$NSD

NASDAQ Market Internals

16:17
01/18/18
01/18
16:17
01/18/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCRI

Monarch Casino

$45.40

-0.5 (-1.09%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Initiation
Monarch Casino initiated  »

Monarch Casino initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVS

Las Vegas Sands

$73.73

0.22 (0.30%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Initiation
Las Vegas Sands initiated  »

Las Vegas Sands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

EPR

EPR Properties

$59.55

-1.24 (-2.04%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Hot Stocks
EPR Properties raises monthly dividend to 36c from 34c »

The dividend of $0.36 per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPP

Green Plains Partners

$18.00

0.1 (0.56%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Hot Stocks
Green Plains Partners increases quarterly distribution »

Green Plains Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFBC

First Financial Bancorp

$27.75

-0.4 (-1.42%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Earnings
First Financial Bancorp reports Q4 EPS 40c, consensus 40c »

Net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

RNR

RenaissanceRe

$121.24

-1.68 (-1.37%)

, APO

Apollo Global

$35.07

-0.35 (-0.99%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Hot Stocks
RenaissanceRe to acquire minority shareholding in Catalina »

Catalina Holdings Ltd and…

RNR

RenaissanceRe

$121.24

-1.68 (-1.37%)

APO

Apollo Global

$35.07

-0.35 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 01

    Feb

GLPI

Gaming and Leisure Properties

$36.42

-0.34 (-0.92%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Initiation
Gaming and Leisure Properties initiated  »

Gaming and Leisure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$175.48

1.89 (1.09%)

16:15
01/18/18
01/18
16:15
01/18/18
16:15
Initiation
Wynn Resorts initiated  »

Wynn Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INDB

Independent Bank

$72.45

-1.5 (-2.03%)

16:15
01/18/18
01/18
16:15
01/18/18
16:15
Earnings
Independent Bank reports Q4 EPS adjusted 89c, consensus 89c »

Total assets of $8.1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

PENN

Penn National

$32.26

-0.49 (-1.50%)

16:15
01/18/18
01/18
16:15
01/18/18
16:15
Initiation
Penn National initiated  »

Penn National initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHDN

Churchill Downs

$252.70

0.5 (0.20%)

16:15
01/18/18
01/18
16:15
01/18/18
16:15
Initiation
Churchill Downs initiated  »

Churchill Downs initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDEN

Golden Entertainment

$28.21

-0.6 (-2.08%)

16:15
01/18/18
01/18
16:15
01/18/18
16:15
Initiation
Golden Entertainment initiated  »

Golden Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

16:15
01/18/18
01/18
16:15
01/18/18
16:15
General news
Breaking General news story  »

Week of 1/8 Money Supply…

16:15
01/18/18
01/18
16:15
01/18/18
16:15
General news
Breaking General news story  »

Week of 1/17 Fed Balance…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.